Back to Index
Christy Ann Russell, MD
Associate Professor of Clinical Medicine
Director of Case Management/Utilization Review At Norris Hospital
NOR 3448 Health Sciences Campus Los Angeles
+1 323 865 3903


Christy Russell, MD, is Associate Professor of Medicine at the Keck School of Medicine of USC, Director of the USC Norris Breast Center and chief of medicine at USC Norris Cancer Hospital. She is a medical oncologist specializing in breast cancer at the USC Norris Comprehensive Cancer Center and as a board certified physician in both internal medicine and medical oncology, Dr. Russell has served as chief of staff and as a member of the Norris Leadership Council.

She received her medical degree from the Medical College of Pennsylvania and trained as a fellow in medical oncology and hematology at LAC+USC Medical Center. Dr. Russell lectures nationally and internationally and has authored numerous publications on breast and testicular cancer. She is a member of the Medical Advisory Board for the Wellness Community in Pasadena and a board member of the American Cancer Society.


Wellness Community- Foothill Branch: Angel Award, 2000

ABC7: Women of Courage Award, 2006

Astra Zeneca Oncology: Visions of Hope Award, 2003

YWCA Pasadena: Woman of Excellence in the Field of Medicine, 2004


Piatek CI, Ji L, Kaur C, Russell CA, Tripathy D, Church T, Sposto R, Sener SF, Garcia AA. Value of routine staging imaging studies for patients with stage III breast cancer. J Surg Oncol. 2016 Dec; 114(8):917-921. View in: PubMed

Wu AH, Spicer D, Garcia A, Tseng CC, Hovanessian-Larsen L, Sheth P, Martin SE, Hawes D, Russell C, MacDonald H, Tripathy D, Su MY, Ursin G, Pike MC. Double-Blind Randomized 12-Month Soy Intervention Had No Effects on Breast MRI Fibroglandular Tissue Density or Mammographic Density. Cancer Prev Res (Phila). 2015 Oct; 8(10):942-51. View in: PubMed

Wecsler JS, Tereffe W, Pedersen RC, Sieffert MR, Mack WJ, Cui H, Russell CA, Woods RR, Viscusi RK, Sener SF, Lang JE. Lymph node status in inflammatory breast cancer. Breast Cancer Res Treat. 2015 May; 151(1):113-20. View in: PubMed

Russell CA. Molecular Profiling for DCIS. Clin Adv Hematol Oncol. 2014 Sep; 12(9):611-3. View in: PubMed

Russell CA. Personalized medicine for breast cancer: it is a new day! Am J Surg. 2014 Mar; 207(3):321-5. View in: PubMed

Schmale I, Liu S, Rayhanabad J, Russell CA, Sener SF. Ductal carcinoma in situ (DCIS) of the breast: Perspectives on biology and controversies in current management. J Surg Oncol. 2012 Feb; 105(2):212-20. View in: PubMed

Russell C. The role of albumin-bound paclitaxel in metastatic breast cancer. Clin Adv Hematol Oncol. 2011 Jun; 9(6):469-71. View in: PubMed

Ellis GK, Barlow WE, Gralow JR, Hortobagyi GN, Russell CA, Royce ME, Perez EA, Lew D, Livingston RB. Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012. J Clin Oncol. 2011 Mar 10; 29(8):1014-21. View in: PubMed

Liu SV, Melstrom L, Yao K, Russell CA, Sener SF. Neoadjuvant therapy for breast cancer. J Surg Oncol. 2010 Mar 15; 101(4):283-91. View in: PubMed

Ell K, Vourlekis B, Xie B, Nedjat-Haiem FR, Lee PJ, Muderspach L, Russell C, Palinkas LA. Cancer treatment adherence among low-income women with breast or gynecologic cancer: a randomized controlled trial of patient navigation. Cancer. 2009 Oct 1; 115(19):4606-15. View in: PubMed

Russell CA. Letrozole as adjuvant therapy for postmenopausal women with early breast cancer. Manag Care Interface. 2007 Sep; 20(9):30-1, 36. View in: PubMed

Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD, Morris E, Pisano E, Schnall M, Sener S, Smith RA, Warner E, Yaffe M, Andrews KS, Russell CA. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007 Mar-Apr; 57(2):75-89. View in: PubMed

Grunberg SM, Weiss MH, Russell CA, Spitz IM, Ahmadi J, Sadun A, Sitruk-Ware R. Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest. 2006 Dec; 24(8):727-33. View in: PubMed

Ell K, Sanchez K, Vourlekis B, Lee PJ, Dwight-Johnson M, Lagomasino I, Muderspach L, Russell C. Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer. J Clin Oncol. 2005 May 1; 23(13):3052-60. View in: PubMed

Li HC, Russell CA. Gemcitabine and platinum-based chemotherapy in metastatic breast cancer. Oncology (Williston Park). 2004 Dec; 18(14 Suppl 12):17-22. View in: PubMed

Lyman GH, Green SJ, Ravdin PM, Geyer Jr CE, Russell CA, Balcerzak SP, Thomas Budd G, Martino S. A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer. Breast Cancer Res Treat. 2004 May; 85(2):143-50. View in: PubMed

Russell CA. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm. Curr Oncol Rep. 2003 Jan; 5(1):72-7. View in: PubMed

Russell CA. Adjuvant systemic therapy for lymph node-negative breast cancer less than or equal to 1 cm. Curr Womens Health Rep. 2002 Apr; 2(2):134-9. View in: PubMed

Powered bySC CTSI